Skip to main content

Salvatore Vincent Pizzo

Professor Emeritus of Pathology
Pathology
Rm 3059 Duke South Hospital, Duke Box 3712, Durham, NC 27710
Rm 3059 Duke South Hospital, Durham, NC 27710

Overview


RESEARCH ABSTRACT
Studies from this laboratory identified cell surface expression of the molecular chaperone GRP78 as a major factor in prostate cancer and other malignancies.  Cell surface GRP78 functions as a signaling receptor promoting tumor proliferation and suppressing apoptosis.  Patients with a number of malignancies mount an autoimmune response to GRP78 and these antibodies, which bind to the NH2 terminal domains of GRP78, are receptor agonists whose appearance is a marker of poor prognosis.  More recently, we have shown that antibodies directed against the COOH-terminal domain of GRP78 are receptor antagonists which may have therapeutic potential for treating patients whose tumors express GRP78 on the cell surface.

Current Duke Appointments & Affiliations


Professor Emeritus of Pathology · 2025 - Present Pathology, Clinical Science Departments

Recent News Items


Published June 28, 2023
New, Early Marker for Heart Disease Discovered

View All News Items

Recent Grants


Development of an Optimized Human Antibody to a Novel Target for the Treatment of Fibrotic Diseases

ResearchPrincipal Investigator · Awarded by North Carolina Biotechnology Center · 2019 - 2020

Tension-Stat3-miR-mediated Metastasis

ResearchInvestigator · Awarded by City of Hope · 2015 - 2017

Clinical Oncology Research Career Development Program

ResearchMentor · Awarded by National Institutes of Health · 2009 - 2015

View All Grants

Education


Duke University · 1973 M.D.
Duke University · 1972 Ph.D.